ECM
ALAB icon

Everence Capital Management’s Astera Labs ALAB Stock Holding History

Everence Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$458K Buy
4,183
+272
+7% +$38.7K 0.03% 404
2025
Q4 		$651K Hold
3,911
– – 0.04% 319
2025
Q3 		$766K Sell
3,911
-399
-9% -$65.6K 0.05% 288
2025
Q2 		$390K Buy
+4,310
New +$341K 0.03% 463
2025
Q1 		– Sell
-3,870
Closed -$513K – 861
2024
Q4 		$513K Buy
+3,870
New +$363K 0.03% 357

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Everence Capital Management's ALAB Position: Q1 2026 in Review

Everence Capital Management increased its Astera Labs (ALAB) stake by 7% in Q1 2026, buying an estimated $38.7K and bringing the position to 4,183 shares worth $458K. The position accounts for 0.03% of the portfolio, ranked #404.

Everence Capital Management first reported a position in ALAB in Q4 2024 and has held it in 5 quarters since. The position peaked at $766K in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Everence Capital Management held 4,183 shares of Astera Labs worth $458K as of Q1 2026.
  • Everence Capital Management bought 272 Astera Labs shares in Q1 2026, an estimated $38.7K.
  • Astera Labs made up 0.03% of Everence Capital Management's portfolio in Q1 2026, its #404 holding.
  • Everence Capital Management first reported a position in Astera Labs in Q4 2024 and has held it in 5 quarters since.
  • Everence Capital Management's Astera Labs position peaked at $766K in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.